Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Strides Pharma Science Limited
  6. News
  7. Summary
    STAR   INE939A01011

STRIDES PHARMA SCIENCE LIMITED

(STAR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Strides Pharma Science : Completes Acquisition of US-Based Endo International's Assets for $24 Million

10/21/2021 | 12:02am EST


ę MT Newswires 2021
All news about STRIDES PHARMA SCIENCE LIMITED
11/10Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six ..
CI
10/21STRIDES PHARMA SCIENCE : Completes Acquisition of US-Based Endo International's Assets for..
MT
10/21Strides Pharma Science Limited completed the acquisition of Manufacturing facility at C..
CI
08/09STRIDES PHARMA SCIENCE : Swings to Loss in Fiscal Q1
MT
08/08STRIDES PHARMA SCIENCE : Appoints New CEO for Biotechnology Arm
MT
08/06FUTURE RETAIL : Indian shares close lower as Reliance drags
RE
08/06Strides Pharma Science Limited Reports Earnings Results for the First Quarter Ended Jun..
CI
08/06STRIDES PHARMA SCIENCE : Units to Acquire US-Based Endo International's Assets for $24 Mil..
MT
08/06STRIDES PHARMA SCIENCE LIMITED (NSEI : STAR) agreed to acquire Manufacturing facility at C..
CI
07/26Strides Pharma Science Limited Recommends Final Dividend for Fiscal Year 2021
CI
More news
Financials
Sales 2022 31 291 M 417 M 417 M
Net income 2022 -3 230 M -43,1 M -43,1 M
Net Debt 2022 17 163 M 229 M 229 M
P/E ratio 2022 -15,1x
Yield 2022 0,59%
Capitalization 44 137 M 590 M 589 M
EV / Sales 2022 1,96x
EV / Sales 2023 1,51x
Nbr of Employees 2 390
Free-Float 77,3%
Chart STRIDES PHARMA SCIENCE LIMITED
Duration : Period :
Strides Pharma Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRIDES PHARMA SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 491,60 INR
Average target price 698,50 INR
Spread / Average Target 42,1%
EPS Revisions
Managers and Directors
Raghunathan Ananthanarayanan Chief Executive Officer, Director & MD
Badree Komandur Group CFO, Finance Director & Executive Director
Arun N. Kumar Chairman
Anjani Kumar Chief Information Officer
Raviraj Pillai Chief Scientific Officer